How Grow Therapy turned insurance friction into a $3 billion startup story

A lot of digital health startups try to win by sounding futuristic. Grow Therapy’s pitch is more grounded and, in some ways, more powerful: make mental healthcare easier to find, easier to pay for, and easier for providers to deliver. That formula just helped the company raise $150 million at a $3 billion valuation, bringing its total funding to $328 million in a Series D led by TCV and Goldman Sachs Alternatives’ growth equity business, with BCI and Menlo Ventures joining. Reuters reported the round in early March, and the company later used its own funding announcement to frame the raise as validation that insurers, employers, and health systems increasingly want a more integrated mental-health access layer.

What makes the company interesting is that it is not selling therapy sessions so much as it is selling coordination. In the Reuters report on Grow Therapy’s latest fundraise, the startup is described as a platform that connects clients with licensed therapists and psychiatrists, offering both in-person and virtual care. Reuters also said the company has partnered with more than 125 health insurers that together provide access to 220 million people. On Grow’s own Series D announcement, the company argues that mental healthcare often fails people when they need it most and says its platform is now being used not just by insurers but also by employers and health systems. That is a very different business from “here’s an app, good luck.” It is a coverage-and-workflow business disguised as a consumer brand.

The scale claims help explain why investors keep leaning in. In the company’s March 2026 funding post, Grow said that more than two million people have used the platform, that it facilitated seven million visits in 2025, and that lifetime therapy and medication-management visits have now reached 10 million.

The same announcement said 9 out of 10 clients would strongly recommend Grow and pegged its Net Promoter Score at 85. Company-provided metrics should always be read with appropriate caution, but taken together they suggest Grow is no longer operating like a small telehealth experiment. It is trying to become the infrastructure layer between patients, providers, and payors.

That is where the startup’s moat starts to look more interesting than the funding headline. Mental healthcare in the United States is full of friction: insurance confusion, clinician shortages, billing headaches, and the exhausting search for a provider who is both available and covered. Grow’s public materials keep returning to the same promise, including on its about page: it sits “at the intersection of people, providers and partners.” For patients, the company says that means there is “no wrong door” to care. For providers, it means less administrative drag. For insurers and employers, it means a partner that can help turn mental-health access into something more coordinated and measurable.

https://www.youtube.com/watch?v=i1wiT43nt48

Grow is also making the now-obligatory AI move, but in a relatively practical way. Reuters reported that the startup is integrating AI into the platform, and a company spokesperson said provider documentation time has fallen by nearly 70% since Grow launched certain AI tools in February 2025, while also claiming the tools exceeded manual note accuracy. Reuters also said the company offers clients between-session support such as AI-powered journaling prompts. That matters because it shows where many health startups are now aiming: not at replacing care, but at reducing the paperwork and lag that surround care. In a field where clinician time is scarce and burnout is common, workflow relief can be as valuable as a flashy front-end feature.

There is, of course, competition circling the same opportunity. Reuters notes that Grow is up against other well-funded mental-health startups such as Headway and Alma, as well as larger players including Teladoc-owned BetterHelp. That makes this more than a feel-good access story. It is a market fight over who gets to become the trusted operating layer for mental healthcare. Some companies are attacking the problem through direct-to-consumer branding. Others are leaning harder into provider software or employer benefits. Grow’s bet appears to be that insurance connectivity, provider enablement, and broad partner relationships will be more defensible than simply being a nice place to search for a therapist.

The broader startup lesson is that some of the strongest businesses are built not by inventing a new human need, but by untangling an old, miserable process. Grow Therapy did not create demand for mental healthcare. It found a way to position itself inside the mess of access, payment, matching, and documentation. That is why the company now looks more like a network business than a lightweight app. And that is also why the latest round matters. A $3 billion valuation here is not just a vote for therapy demand. It is a vote for the idea that the next big health startup may win by making a fragmented system feel, finally, a little more usable.